Similar Papers

Paper Title
Journal
Date
Author
Abstract 1837: Overcoming trastuzumab resistance in HER2-overexpressing breast cancer by utilizing PHB2, a tumor suppressor of multiple resistance pathways
Tetsuro Yoshimaru ... Toyomasa Katagiri
Cancer Research | VOL. 78
Tetsuro Yoshimaru, et. al.Tetsuro Yoshimaru ... Toyomasa Katagiri
01 Jul 2018
MiR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.
Claire Corcoran ... Lorraine O'Driscoll
Molecular cancer | VOL. 13
Claire Corcoran, et. al.Claire Corcoran ... Lorraine O'Driscoll
24 Mar 2014
Concordance Between Central and Local Laboratory HER2 Testing from a Community-Based Clinical Study
Josina C Reddy ... Pamela M Klein
Clinical Breast Cancer | VOL. 7
Josina C Reddy, et. al.Josina C Reddy ... Pamela M Klein
01 Jun 2006
Abstract P4-10-16: Long term effects of trastuzumab on cardiopulmonary and left ventricular function in women with HER2 overexpressing breast cancer
E Pituskin ... I Paterson
Cancer Research | VOL. 76
E Pituskin, et. al.E Pituskin ... I Paterson
15 Feb 2016
View more papers

More From: Molecular Cancer

Paper Title
Journal
Date
Author
CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance
Xuemeng Xu ... Qianjin Liao
Molecular Cancer | VOL. 24
Xuemeng Xu, et. al.Xuemeng Xu ... Qianjin Liao
31 Jan 2025
lncRNAs: the unexpected link between protein synthesis and cancer adaptation
Mila Gugnoni ... Alessia Ciarrocchi
Molecular Cancer | VOL. 24
Mila Gugnoni, et. al.Mila Gugnoni ... Alessia Ciarrocchi
31 Jan 2025
Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment
Zhenyun Yang ... Minshan Chen
Molecular Cancer | VOL. 24
Zhenyun Yang, et. al.Zhenyun Yang ... Minshan Chen
31 Jan 2025
Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
Claire Corcoran ... Lorraine O'Driscoll
Molecular Cancer | VOL. 24
Claire Corcoran, et. al.Claire Corcoran ... Lorraine O'Driscoll
31 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.